214 related articles for article (PubMed ID: 16118457)
1. Animal models of pulmonary fibrosis.
Gharaee-Kermani M; Ullenbruch M; Phan SH
Methods Mol Med; 2005; 117():251-9. PubMed ID: 16118457
[TBL] [Abstract][Full Text] [Related]
2. [Experimentally induced bleomycin pulmonary toxicity--comparison of the systemic (intraperitoneal) and local (intratracheal) administration].
Ekimoto H; Takahashi K; Matsuda A; Umezawa H
Gan To Kagaku Ryoho; 1983 Dec; 10(12):2550-7. PubMed ID: 6197032
[TBL] [Abstract][Full Text] [Related]
3. High dose continuous infusion of bleomycin in mice: a new model for drug-induced pulmonary fibrosis.
Harrison JH; Lazo JS
J Pharmacol Exp Ther; 1987 Dec; 243(3):1185-94. PubMed ID: 2447265
[TBL] [Abstract][Full Text] [Related]
4. VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice.
Ou XM; Li WC; Liu DS; Li YP; Wen FQ; Feng YL; Zhang SF; Huang XY; Wang T; Wang K; Wang X; Chen L
Int Immunopharmacol; 2009 Jan; 9(1):70-9. PubMed ID: 18976720
[TBL] [Abstract][Full Text] [Related]
5. Immunomodulation of experimental pulmonary fibrosis by intravenous immunoglobulin (IVIG).
Molina V; Haj-Yahia S; Solodeev I; Levy Y; Blank M; Shoenfeld Y
Autoimmunity; 2006 Dec; 39(8):711-7. PubMed ID: 17178568
[TBL] [Abstract][Full Text] [Related]
6. Increase in p21 expression independent of the p53 pathway in bleomycin-induced lung fibrosis.
Blundell R; Kaminski N; Harrison D
Exp Mol Pathol; 2004 Dec; 77(3):231-7. PubMed ID: 15507241
[TBL] [Abstract][Full Text] [Related]
7. A novel model for human interstitial lung disease: hapten-driven lung fibrosis in rodents.
Roberts SN; Howie SE; Wallace WA; Brown DM; Lamb D; Ramage EA; Donaldson K
J Pathol; 1995 Jul; 176(3):309-18. PubMed ID: 7674093
[TBL] [Abstract][Full Text] [Related]
8. Extensive laminin and basement membrane accumulation occurs at the onset of bleomycin-induced rodent pulmonary fibrosis.
Singer II; Kawka DW; McNally SM; Eiermann GJ; Metzger JM; Peterson LB
Am J Pathol; 1986 Nov; 125(2):258-68. PubMed ID: 2431622
[TBL] [Abstract][Full Text] [Related]
9. Heparin attenuates bleomycin but not silica-induced pulmonary fibrosis in mice: possible relationship with involvement of myofibroblasts in bleomycin, and fibroblasts in silica-induced fibrosis.
Piguet PF; Van GY; Guo J
Int J Exp Pathol; 1996 Aug; 77(4):155-61. PubMed ID: 8943733
[TBL] [Abstract][Full Text] [Related]
10. Kinetics of inflammatory and fibrotic pulmonary changes in a murine model of silicosis.
Callis AH; Sohnle PG; Mandel GS; Wiessner J; Mandel NS
J Lab Clin Med; 1985 May; 105(5):547-53. PubMed ID: 2985721
[TBL] [Abstract][Full Text] [Related]
11. Simvastatin attenuates bleomycin-induced pulmonary fibrosis in mice.
Ou XM; Feng YL; Wen FQ; Huang XY; Xiao J; Wang K; Wang T
Chin Med J (Engl); 2008 Sep; 121(18):1821-9. PubMed ID: 19080365
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of emodin on bleomycin-induced pulmonary fibrosis in mice.
Chen XH; Sun RS; Hu JM; Mo ZY; Yang ZF; Jin GY; Guan WD; Zhong NS
Clin Exp Pharmacol Physiol; 2009 Feb; 36(2):146-53. PubMed ID: 18785980
[TBL] [Abstract][Full Text] [Related]
13. Epigallocatechin-3-gallate exhibits anti-fibrotic effect by attenuating bleomycin-induced glycoconjugates, lysosomal hydrolases and ultrastructural changes in rat model pulmonary fibrosis.
Sriram N; Kalayarasan S; Sudhandiran G
Chem Biol Interact; 2009 Jul; 180(2):271-80. PubMed ID: 19497426
[TBL] [Abstract][Full Text] [Related]
14. FITC-induced murine pulmonary inflammation: CC10 up-regulation and concurrent Shh expression.
Fisher CE; Ahmad SA; Fitch PM; Lamb JR; Howie SE
Cell Biol Int; 2005 Oct; 29(10):868-76. PubMed ID: 16150617
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of MMP9 in macrophages attenuates pulmonary fibrosis induced by bleomycin.
Cabrera S; Gaxiola M; Arreola JL; RamÃrez R; Jara P; D'Armiento J; Richards T; Selman M; Pardo A
Int J Biochem Cell Biol; 2007; 39(12):2324-38. PubMed ID: 17702637
[TBL] [Abstract][Full Text] [Related]
16. Cysteinyl-leukotriene 1 receptor antagonist attenuates bleomycin-induced pulmonary fibrosis in mice.
Izumo T; Kondo M; Nagai A
Life Sci; 2007 Apr; 80(20):1882-6. PubMed ID: 17397875
[TBL] [Abstract][Full Text] [Related]
17. Exacerbation of bleomycin-induced injury and fibrosis by pneumonectomy in the residual lung of mice.
Kakizaki T; Kohno M; Watanabe M; Tajima A; Izumi Y; Miyasho T; Tasaka S; Fukunaga K; Maruyama I; Ishizaka A; Kobayashi K
J Surg Res; 2009 Jun; 154(2):336-44. PubMed ID: 19118846
[TBL] [Abstract][Full Text] [Related]
18. Animal model of human disease. Diffuse interstitial pulmonary fibrosis. Pulmonary fibrosis in mice induced by treatment with butylated hydroxytoluene and oxygen.
Haschek WM; Brody AR; Klein-Szanto AJ; Witschi H
Am J Pathol; 1981 Dec; 105(3):333-5. PubMed ID: 7315951
[No Abstract] [Full Text] [Related]
19. CD19 regulates the development of bleomycin-induced pulmonary fibrosis in a mouse model.
Komura K; Yanaba K; Horikawa M; Ogawa F; Fujimoto M; Tedder TF; Sato S
Arthritis Rheum; 2008 Nov; 58(11):3574-84. PubMed ID: 18975313
[TBL] [Abstract][Full Text] [Related]
20. Time course of pulmonary response of rats to inhalation of crystalline silica: histological results and biochemical indices of damage, lipidosis, and fibrosis.
Porter DW; Ramsey D; Hubbs AF; Battelli L; Ma J; Barger M; Landsittel D; Robinson VA; McLaurin J; Khan A; Jones W; Teass A; Castranova V
J Environ Pathol Toxicol Oncol; 2001; 20 Suppl 1():1-14. PubMed ID: 11570667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
